SCHEMBL24305688

SCHEMBL24305688

CCCCNc1nc(C)nc2c1oc1cccc(CCCCNc3nc(C)nc4sc(C)c(C)c34)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.42
▸ KDM4E B2RXH2 6/20 0.42
▸ MAPK1 P28482 5/20 0.42
▸ LMNA P02545 7/20 0.42
▸ HTT P42858 7/20 0.42
▸ SMN1; SMN2 Q16637 6/20 0.42
▸ MAPT P10636 4/20 0.41
▸ GAA P10253 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ HSD17B10 Q99714 2/20 0.38
▸ TSHR P16473 2/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ TP53 P04637 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ RAF1 P04049 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ PLA2G1B P04054 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20667980 0.77 SMN1; SMN2 (0.53) ALDH1A1KDM4EMAPK1LMNAHTT
SCHEMBL20667990 0.71 KDM4E (0.72) ALDH1A1KDM4EMAPK1LMNAHTT
SCHEMBL20667975 0.67 HTT (0.69) ALDH1A1KDM4EMAPK1LMNAHTT
SCHEMBL20668099 0.65 GAA (0.68) ALDH1A1KDM4EMAPK1LMNAHTT
SCHEMBL20667991 0.62 LMNA (0.86) ALDH1A1KDM4EMAPK1LMNAHTT
SCHEMBL20667994 0.59 KDM4E (0.75) ALDH1A1KDM4EMAPK1LMNAHTT
SCHEMBL20659861 0.58 MAPT (0.65) ALDH1A1KDM4EMAPK1LMNAHTT
SCHEMBL20667920 0.58 MAPT (0.62) ALDH1A1KDM4EMAPK1LMNAHTT
SCHEMBL20667974 0.57 KDM4E (0.51) ALDH1A1KDM4ELMNASMN1; SMN2HSD17B10
SCHEMBL28561887 0.56 LIPG (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220117968-A1 THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS SAINT LOUIS UNIVERSITY 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220117968-A1 THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS TYMS, DPYD, UMPS ALDH1A1 924/4885KDM4E 2186/4885MAPK1 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback